Related Articles
Precision medicine based on tumorigenic signaling pathways for triple‑negative breast cancer (Review)
MELK as a potential target to control cell proliferation in triple‑negative breast cancer MDA‑MB‑231 cells
NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
Bufalin attenuates triple‑negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4